Pharmaceutical Filtration Services Market Overview:
According to SPER Market Research, the Pharmaceutical Filtration Market is estimated to reach USD 36.13 billion by 2030 with a CAGR of 15.6%. The increasing adoption of single-use technologies, a rising number of new product launches by leading market players, increasing purity requirements in end user segments, and increasing advances in nanofiber technology are all contributing to the pharmaceutical filtration market's growth. Membrane fouling, on the other hand, is expected to supress market growth, as is the high capital investment required to set up new manufacturing facilities.
Impact of COVID-19 on the Pharmaceutical Filtration Market
With the World Health Organization (WHO) calling the COVID-19 outbreak a pandemic, a number of prominent pharmaceutical and biopharmaceutical businesses have increased their R&D and production efforts to create and market SARS-CoV-2 viral test kits, vaccines, and treatments. The pandemic's economic and social costs have driven governments around the world to increase funding for vaccine development and production, resulting in a rise in the use of pharmaceutical filtration products in COVID-19 research and production. In the research and manufacture of vaccinations, many filtration technologies are utilized.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2019-2030 |
| Base year considered | 2021 |
| Forecast period | 2022-2030 |
| Segments covered | By Product, By Systems, By Technique, By Application, By Scale of Operation
|
| Geographies covered | North America, Europe, Asia Pacific, Latin America, Middle East, Africa |
| Companies Covered | Alfa Laval Corporate AB, Amazon Filters LTD, Cantel Medical Corp., Cole-Parmer Instrument Company LCC., Corning Incorporated., Donaldson Company, Inc., Danaher Corporation, Eaton Corporation PLC., Ertelalsop, Filtrox AG., Freudenberg Filtration Technologies SE & CO.KG, Graver Technologies, LLC., Kasag Swiss AG., Membrane Solutions., Merck KGAA. , MMS AG., Mann + Hummel International GMBH & CO. KG, Meissner Filtration Products, INC., Parker + Hannifin Corporation , Porvair PLC. , Repligen Corporation., Saint-Gobain Performance Plastics. , Sartorius AG. , 3M Company.
|
Driver: Increase adoption of Single use technologies.
Single-use technologies require less space, capital investment, and sterilization than reusable systems. This lowers the total operating and maintenance expenses as well as the impact of these activities on the environment. End users have been able to attain regulatory compliance for their processes at a lower cost using these solutions. As a result, single-use or disposable solutions have proven to be a key technical advancement in the pharmaceutical filtration sector, with their enormous benefits driving end-user demand and, by extension, market expansion.
Restraint: Challanges in membrane fouling to restain market growth.
When compared to other filtration technologies such as tubular or spiral-wound components, these filters are more prone to break due to the flexibility of the fibers. In comparison to alternative arrangements, membrane filters have reasonable capital costs but high operating expenses. Pharmaceutical filters in biopharmaceutical filtering processes are difficult to use because of their high cost and membrane fouling concerns.
Opportunity: Nanofiltration can benefits from advancements in nanofiber technology.
Nanofiltration, which separates molecules present in organic solvents, has a lot of potential in sectors ranging from refining to fine chemical and pharmaceutical production. As a result, market growth is likely to be driven by advancements in nanofiber technology throughout the forecast period.
Challenges: Increased cost reduced speed and yield.
Pharmaceutical filters are subjected to comprehensive lot release testing to verify that they operate to specifications. Manufacturers execute 100 percent integrity testing on sterilizing filters, as well as relevant validation tests, to verify conformity with specified requirements. Some bigger producers do further lot release testing to determine the amount of germs retained in each lot. In-house testing necessitates costly equipment and carefully qualified experts, raising the price of pharmaceutical filters. Additionally, because some present downstream activities, such as nanofiltration, are not compatible with continuous processing, speed of processing and avoiding bottlenecks are part of the efficiency problem. This diminishes yield and increases the amount of time and effort required, posing problems for subsequent processing.
Pharmaceutical Filtration Market Segmentation:
By Product: Based on the Product of Pharmaceutical Filtration Market is segment as; Filters [Membrane Filters {Polyethersulfone (PES), Polyvinylidene Difluoride (PVDF), Nylon, Polyetrafluoroethylene (PTFE), Mixed Cellulose Ester & Cellulose Acetate (MCE & CA), Polycarbonate Tracked Etched (PCTE), Other Materials}], Depth Filters [{Diatomaceous Earth (Diatomaceous Earth to be used in-depth filters in biotechnology industry for cell clarification)} , {Cellulose (Cost-effectiveness of cellulose-based depth filter to drive market growth)}, {Activated Carbon (Reliable and economic activated carbon filters to be used in traditional pharmaceutical manufacturing operations)}, {Perlite (Perlite is lower in density to provide more purity than diatomaceous earth)}, Other Depth Filter Media ] , Other Filters, Systems {Single-use systems (Reduced need for product validation and minimized cross-contamination risk to boost single-use systems adoption)}, {Reusable systems (Reusable systems to be used for large-scale manufacturing)}, Other Filtration Products {Filtration Assemblies, Filter Holder (Filter holders to provide structural support to membrane filters), Filtration Accessories( Increased in pharmaceutical filtration products adoption to support associated accessories used)}.
By Techniques: Based on the Techniques of Pharmaceutical Filtration Market is segment as; Microfiltration (Increased adoption of Microfiltration Technique and cost-effective nature to propel Market growth), Ultrafiltration (Adoption of Fine Filtration Technique to drive Market growth), Nanofiltration (High energy Consumption to hider Market growth) Other Techniques (High Purity water requirement during Biopharmaceutical manufacturing to increase Market growth).
By Types: Based on the Types of Pharmaceutical Filtration Market is segment as; Sterile Filtration (Increased manufacturing of Biologics drugs to drive sterile filtration demand), Non -Sterile Filtration (Growth of R&D activities to promote Market growth).
By Applications: Based on the Applications of Pharmaceutical Filtration Market is segment as; Final Product Processing {Active Pharmaceutical Ingredient (API) Filtration (Continuous filtration of API filtration to increase market growth), Protein Purification (Recent advancement in protein therapeutic drugs to propel market growth) , Vaccine and Antibody Processing (Rise in COVID-19 pandemic and other viral diseases to drive vaccine and antibody processing market), Formulation and Filling Solutions (Demand for aseptic filling and bioburden reduction to increase market growth), Viral Clearance (Growth in therapeutic monoclonal antibodies to increase market growth)}, Raw Materials Filtration {Media Buffer Filtration (Growth in manufacturing of biopharmaceuticals to improve market growth), Prefiltration (Membrane fouling to increase market growth for prefilters) , Bioburden Testing (Strict quality control of biopharmaceuticals to improve market growth)}, Cell Separation (Growth in personalized medicine to improve market growth), Water Purification ( Growth in aged population to improve market growth) , Air Purification (Increased adoption of GMP practices to improve market growth)}.
By Scale of Operation: Based on the Scale of Operation of Pharmaceutical Filtration Market is segment as; Manufacturing Scale Operation (Expansion by pharmaceuticals to manufacture Covid-19 drugs to drive market growth), Pilot Scale Operation (Increased outsourcing and cost-effective nature to promote market growth), R&D Scale Operation (Expenditure for R&D of Biologics to increase market growth).
By Region: North America and Asia-Pacific region owns the prime share of this market due to rising incidence rate of viral diseases, the need to maintain a clean manufacturing environment because of strict regulatory rule.
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Pharmaceutical Filtration Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Pharmaceutical Filtration Market, By Product, 2019-2030 (USD Million)
6.1 Introduction
6.2. Filter
6.2.1 Membrane Filters
6.2.1.1.Polyethersulfone (PES)
6.2.1.2 Polyvinylidene difluoride (PVDF)
6.2.1.3 Nylon
6.2.1.4 Polytetrafluroethylene (PTFE)
6.2.1.5. Mixed cellulose ester & cellulose acetate (MCE & CA)
6.2.1.6 Polycarbonated Track-Etched (PCTE)
6.2.1.7 Other materials
6.2.2 Depth Filters
6.2.2.1 Diatomaceous earth
6.2.2.1.1. Diatomaceous Earth to be used in-depth filters in biotechnology industry for cell clarification
6.2.2.2 Cellulose
6.2.2.2.1. Cost-effectiveness of cellulose-based depth filter to drive market growth.
6.2.2.3 Activated Carbon
6.2.2.3.1. Reliable and economic activated carbon filters to be used in traditional pharmaceutical manufacturing operations.
6.2.2.4 Perlite
6.2.2.4.1. Perlite is lower in density to provide more purity than diatomaceous earth
6.2.2.5 Other Depth Filter Media
6.2.3 Other Filters
6.3 Systems
6.3.1 Single-use systems
6.3.1.1. Reduced need for product validation and minimized cross-contamination risk to boost single-use systems adoption
6.3.2 Reusable systems
6.3.2.1. Reusable systems to be used for large-scale manufacturing
6.4 Other Filtration Products
6.4.1 Filtration Assemblies
6.4.2 Filter Holder
6.4.2.1. Filter holders to provide structural support to membrane filters
6.4.3 Filtration Accessories
6.4.3.1. Increase in pharmaceutical filtration products adoption to support associated accessories used
7. Pharmaceutical Filtration Market, By Technique, 2019-2030 (USD Million)
7.1. Introduction
7.2. Microfiltration
7.2.1. Increased adoption of Microfiltration Technique and cost-effective nature to propel Market growth
7.3. Ultrafiltration
7.3.1. Adoption of Fine Filtration Technique to drive Market growth
7.4. Nanofiltration
7.4.1. High energy Consumption to hider Market growth
7.5. Other Techniques
7.5.1. High Purity water requirement during Biopharmaceutical manufacturing to increase Market growth
8. Pharmaceutical Filtration Market, By Type, 2019-2030 (USD Million)
8.1. Introduction
8.2. Sterile Filtration
8.2.1. Increased manufacturing of Bilogics drugs to drive sterile filtration demand.
8.3. Non sterile Filtration
8.3.1. Growth of R&D activities to promote Market growth
9. Pharmaceutical Filtration Market, By Applications, 2019-2030 (USD Million)
9.1 Introduction
9.2 Final Product Processing
9.2.1 Active Pharmaceutical Ingredients (API) Filtration
9.2.1.1. Continuous filtration of API filtration to increase market growth
9.2.2 Protein Purification
9.2.2.1. Recent advancement in protein therapeutic drugs to propel market growth
9.2.3 Vaccine and Antibody Processing
9.2.3.1. Rise in COVID-19 pandemic and other viral diseases to drive vaccine and antibody processing market
9.2.4 Formulation and Filling Solutions
9.2.4.1. Demand for aseptic filling and bioburden reduction to increase market growth
9.2.5 Viral Clearance
9.2.5.1. Growth in therapeutic monoclonal antibodies to increase market growth
9.3 Raw Material Filtration
9.3.1 Media Buffer Filtration
9.3.1.1. Growth in manufacturing of biopharmaceuticals to improve market growth
9.3.2 Prefiltration
9.3.2.1. Membrane fouling to increase market growth for prefilters
9.3.3 Bioburden Testing
9.3.3.1. Strict quality control of biopharmaceuticals to improve market growth
9.4 Cell Seperation
9.4.1. Growth in personalized medicine to improve market growth
9.5 Water Purification
9.5.1. Growth in aged population to improve market growth
9.6 Air Purification
9.6.1. Increased adoption of GMP practices to improve market growth
10. Pharmaceutical Filtration Market, By Scale of Operation 2019-2030 (USD Million)
10.1 Introduction
10.2 Manufacturing-Scale Operation
10.2.1. Expansion by pharmaceuticals to manufacture Covid-19 drugs to drive market growth
10.3 Pilot-Scale Operation
10.3.1. Increased outsourcing and cost-effective nature to promote market growth
10.4 R&D-Scale of Operation
10.4.1. Expenditure for R&D of Biologics to increase market growth
11. Pharmaceutical Filtration Market by Region, 2019-2030 (USD Million)
11.1. North America
11.1.1. United States
11.1.2. Canada
11.1.3. Mexico
11.2. Europe
11.2.1. Germany
11.2.2. United Kingdom
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. Japan
11.3.3. India
11.3.4. Australia
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. South America
11.4.1. Brazil
11.4.2. Argentina
11.4.3. Rest of South America
11.5. Middle East & Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Rest of Middle East & Africa
12. Company Profiles
12.1. Alfa Laval Corporate AB
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Amazon Filters LTD.
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Cantel Medical Corp.
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Cole-Parmer Instrument Company LCC.
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Corning Incorporated.
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Donaldson Company, Inc.
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Danaher Corporation
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Eaton Corporation PLC.
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Ertelalsop
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Filtrox AG.
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Freudenberg Filtration Technologies SE & CO.KG
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
12.12. Graver Technologies, LLC.
12.12.1. Company details
12.12.2. Financial outlook
12.12.3. Product summary
12.12.4. Recent developments
12.13. Kasag Swiss AG.
12.13.1. Company details
12.13.2. Financial outlook
12.13.3. Product summary
12.13.4. Recent developments
12.14. Membrane Solutions.
12.14.1. Company details
12.14.2. Financial outlook
12.14.3. Product summary
12.14.4. Recent developments
12.15. Merck KGAA.
12.15.1. Company details
12.15.2. Financial outlook
12.15.3. Product summary
12.15.4. Recent developments
12.16. MMS AG
12.16.1. Company details
12.16.2. Financial outlook
12.16.3. Product summary
12.16.4. Recent developments
12.17. Mann + Hummel International GMBH & CO. KG
12.17.1. Company details
12.17.2. Financial outlook
12.17.3. Product summary
12.17.4. Recent developments
12.18. Meissner Filtration Products, INC.
12.18.1. Company details
12.18.2. Financial outlook
12.18.3. Product summary
12.18.4. Recent developments
12.19. Parker + Hannifin Corporation.
12.19.1. Company details
12.19.2. Financial outlook
12.19.3. Product summary
12.19.4. Recent developments
12.20. Porvair PLC.
12.20.1. Company details
12.20.2. Financial outlook
12.20.3. Product summary
12.20.4. Recent developments
12.21. Repligen Corporation.
12.21.1. Company details
12.21.2. Financial outlook
12.21.3. Product summary
12.21.4. Recent developments
12.22. Saint-Gobain Performance Plastics.
12.22.1. Company details
12.22.2. Financial outlook
12.22.3. Product summary
12.22.4. Recent developments
12.23. Sartorius AG.
12.23.1. Company details
12.23.2. Financial outlook
12.23.3. Product summary
12.23.4. Recent developments
12.24. 3M Company.
12.24.1. Company details
12.24.2. Financial outlook
12.24.3. Product summary
12.24.4. Recent developments